BIOMAT Database Logo BIOMAT Database Logo

Structure of the monophosphoryl lipid A moiety obtained from the lipopolysaccharide of Chlamydia trachomatis. 1997

N Qureshi, and I Kaltashov, and K Walker, and V Doroshenko, and R J Cotter, and K Takayama, and T R Sievert, and P A Rice, and J S Lin, and D T Golenbock
Mycobacteriology Research Laboratory, William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin 53705, USA.

Monophosphoryl lipid A was prepared from the lipopolysaccharide of Chlamydia trachomatis, converted to the methyl ester, and fractionated by reverse-phase high-performance liquid chromatography. The peak fractions were collected and analyzed by mass spectrometry. Matrix-assisted laser desorption/ionization and liquid secondary ion mass spectrometry of the first of two major high-performance liquid chromatographic fractions showed multiple quasi-molecular ions of MNa+ at m/z 1780, 1794, 1808, 1822, and 1836. The positive-ion liquid secondary ion mass spectrometry spectrum also showed a minor series of peaks at m/z 1916, 1930, 1944, 1958, and 1971, consistent with the formation of matrix adducts with 3-nitrobenzyl alcohol. Oxonium ions representing the distal subunit were observed at m/z 1057, 1071, 1085, 1099, and 1113. The second fraction was similarly analyzed and found to contain structural homologs of the first fraction. Based on this study, the major lipid A component of chlamydial lipopolysaccharide is a glucosamine disaccharide that contains five fatty acids and a phosphate in the distal segment. Three fatty acyl groups are in the distal segment, and two are in the reducing end segment. The acyloxyacyl group is located in the distal segment in amide linkage. Two structural series, differing by 14 atomic mass units in the reducing subunit, were observed. Chlamydial lipid A is complex and consists of at least 20 homologous structural components. The relatively low potency of Chlamydia trachomatis lipopolysaccharide in activating lipopolysaccharide-responsive cells might be related to the unusual fatty acid composition of the lipid A moiety.

UI MeSH Term Description Entries
D008050 Lipid A Lipid A is the biologically active component of lipopolysaccharides. It shows strong endotoxic activity and exhibits immunogenic properties.
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D002692 Chlamydia trachomatis Type species of CHLAMYDIA causing a variety of ocular and urogenital diseases.
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004187 Disaccharides Oligosaccharides containing two monosaccharide units linked by a glycosidic bond. Disaccharide
D005227 Fatty Acids Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed) Aliphatic Acid,Esterified Fatty Acid,Fatty Acid,Fatty Acids, Esterified,Fatty Acids, Saturated,Saturated Fatty Acid,Aliphatic Acids,Acid, Aliphatic,Acid, Esterified Fatty,Acid, Saturated Fatty,Esterified Fatty Acids,Fatty Acid, Esterified,Fatty Acid, Saturated,Saturated Fatty Acids
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D018629 Spectrometry, Mass, Secondary Ion A mass-spectrometric technique that is used for microscopic chemical analysis. A beam of primary ions with an energy of 5-20 kiloelectronvolts (keV) bombards a small spot on the surface of the sample under ultra-high vacuum conditions. Positive and negative secondary ions sputtered from the surface are analyzed in a mass spectrometer in regards to their mass-to-charge ratio. Digital imaging can be generated from the secondary ion beams and their intensity can be measured. Ionic images can be correlated with images from light or other microscopy providing useful tools in the study of molecular and drug actions. Mass Spectrometry, Secondary Ion,Mass Spectroscopy, Secondary Ion,SIMS Microscopy,Secondary Ion Mass Spectrometry,Secondary Ion Mass Spectrometry Microscopy,Spectroscopy, Mass, Secondary Ion,Secondary Ion Mass Spectroscopy,Secondary Ion Mass Spectroscopy Microscopy
D019032 Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization A mass spectrometric technique that is used for the analysis of large biomolecules. Analyte molecules are embedded in an excess matrix of small organic molecules that show a high resonant absorption at the laser wavelength used. The matrix absorbs the laser energy, thus inducing a soft disintegration of the sample-matrix mixture into free (gas phase) matrix and analyte molecules and molecular ions. In general, only molecular ions of the analyte molecules are produced, and almost no fragmentation occurs. This makes the method well suited for molecular weight determinations and mixture analysis. Laser Desorption-Ionization Mass Spectrometry, Matrix-Assisted,MALD-MS,MALDI,Mass Spectrometry, Matrix-Assisted Laser Desorption-Ionization,Mass Spectroscopy, Matrix-Assisted Laser Desorption-Ionization,Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry,Spectroscopy, Mass, Matrix-Assisted Laser Desorption-Ionization,MALDI-MS,MS-MALD,SELDI-TOF-MS,Surface Enhanced Laser Desorption Ionization Mass Spectrometry,Laser Desorption Ionization Mass Spectrometry, Matrix Assisted,MALDI MS,Mass Spectrometry, Matrix Assisted Laser Desorption Ionization,Mass Spectroscopy, Matrix Assisted Laser Desorption Ionization,Matrix Assisted Laser Desorption Ionization Mass Spectrometry

Related Publications

N Qureshi, and I Kaltashov, and K Walker, and V Doroshenko, and R J Cotter, and K Takayama, and T R Sievert, and P A Rice, and J S Lin, and D T Golenbock
Structural characterization of monophosphoryl lipid A homologs obtained from Salmonella minnesota Re595 lipopolysaccharide.
May 1990, The Journal of biological chemistry,
N Qureshi, and I Kaltashov, and K Walker, and V Doroshenko, and R J Cotter, and K Takayama, and T R Sievert, and P A Rice, and J S Lin, and D T Golenbock
The lipid A from Vibrio fischeri lipopolysaccharide: a unique structure bearing a phosphoglycerol moiety.
June 2011, The Journal of biological chemistry,
N Qureshi, and I Kaltashov, and K Walker, and V Doroshenko, and R J Cotter, and K Takayama, and T R Sievert, and P A Rice, and J S Lin, and D T Golenbock
Monophosphoryl lipid A inhibits neutrophil priming by lipopolysaccharide.
August 1990, The Journal of laboratory and clinical medicine,
N Qureshi, and I Kaltashov, and K Walker, and V Doroshenko, and R J Cotter, and K Takayama, and T R Sievert, and P A Rice, and J S Lin, and D T Golenbock
Structural analysis of the lipopolysaccharide from Chlamydia trachomatis serotype L2.
June 1999, The Journal of biological chemistry,
N Qureshi, and I Kaltashov, and K Walker, and V Doroshenko, and R J Cotter, and K Takayama, and T R Sievert, and P A Rice, and J S Lin, and D T Golenbock
Chemical characterization of Chlamydia trachomatis lipopolysaccharide.
May 1985, Infection and immunity,
N Qureshi, and I Kaltashov, and K Walker, and V Doroshenko, and R J Cotter, and K Takayama, and T R Sievert, and P A Rice, and J S Lin, and D T Golenbock
Antigenic properties of Chlamydia trachomatis lipopolysaccharide.
May 1985, Infection and immunity,
N Qureshi, and I Kaltashov, and K Walker, and V Doroshenko, and R J Cotter, and K Takayama, and T R Sievert, and P A Rice, and J S Lin, and D T Golenbock
Immunoelectron microscopy of lipopolysaccharide in Chlamydia trachomatis.
October 1989, Infection and immunity,
N Qureshi, and I Kaltashov, and K Walker, and V Doroshenko, and R J Cotter, and K Takayama, and T R Sievert, and P A Rice, and J S Lin, and D T Golenbock
Is lipopolysaccharide a factor in infectivity of Chlamydia trachomatis?
March 2008, Journal of medical microbiology,
N Qureshi, and I Kaltashov, and K Walker, and V Doroshenko, and R J Cotter, and K Takayama, and T R Sievert, and P A Rice, and J S Lin, and D T Golenbock
Lipopolysaccharide in cells infected by Chlamydia trachomatis.
August 1994, Microbiology (Reading, England),
N Qureshi, and I Kaltashov, and K Walker, and V Doroshenko, and R J Cotter, and K Takayama, and T R Sievert, and P A Rice, and J S Lin, and D T Golenbock
Acute respiratory response of guinea pigs to lipopolysaccharide, lipid A, and monophosphoryl lipid A from Salmonella minnesota.
November 1989, The American review of respiratory disease,
Copied contents to your clipboard!